YANKCOM Partnership’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.2M Sell
15,143
-1,219
-7% -$168K 0.76% 29
2026
Q2
$2.1M Sell
16,362
-107
-0.6% -$12.5K 0.75% 29
2026
Q1
$1.98M Hold
16,469
– – 0.81% 24
2025
Q4
$1.73M Buy
16,469
+35
+0.2% +$3.28K 0.74% 31
2025
Q3
$1.38M Buy
16,434
+721
+5% +$59.4K 0.62% 38
2025
Q2
$1.24M Buy
15,713
+698
+5% +$55.5K 0.61% 43
2025
Q1
$1.35M Buy
15,015
+1,353
+10% +$126K 0.74% 35
2024
Q4
$1.36M Buy
+13,662
New +$1.41M 0.73% 33

Other funds holding MRK

YANKCOM Partnership's MRK Position: Q3 2026 in Review

YANKCOM Partnership reduced its Merck (MRK) stake by 7.5% in Q3 2026, selling an estimated $168K and leaving 15,143 shares worth $2.2M. The position accounts for 0.76% of the portfolio, ranked #29.

YANKCOM Partnership first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 2,771 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • YANKCOM Partnership held 15,143 shares of Merck worth $2.2M as of Q3 2026.
  • YANKCOM Partnership sold 1,219 Merck shares in Q3 2026, an estimated $168K.
  • Merck made up 0.76% of YANKCOM Partnership's portfolio in Q3 2026, its #29 holding.
  • YANKCOM Partnership first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 2,771 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.